to create a demonstration law enforcement program to 
prevent opioid and heroin overdose death. 
‘‘(c) APPLICATION.— 
‘‘(1) IN GENERAL.—An eligible entity desiring a 
grant under this section shall submit an application 
to the Attorney General— 
‘‘(A) that meets the criteria under para-
graph (2); and 
‘‘(B) at such time, in such manner, and 
accompanied by such information as the Attor-
ney General may require. 
‘‘(2) CRITERIA.—An eligible entity, in submit-
ting an application under paragraph (1), shall— 
‘‘(A) describe the evidence-based method-
ology and outcome measurements that will be 
used to evaluate the program funded with a 
grant under this section, and specifically ex-
plain how such measurements will provide valid 
measures of the impact of the program; 
‘‘(B) describe how the program could be 
broadly replicated if demonstrated to be effec-
tive; 
‘‘(C) identify the governmental and com-
munity agencies that the program will coordi-
nate; and 
VerDate Sep 11 2014 
02:36 Feb 25, 2015
Jkt 049200
PO 00000
Frm 00032
Fmt 6652
Sfmt 6201
E:\BILLS\H953.IH
H953
emcdonald on DSK67QTVN1PROD with BILLS
‘‘(D) describe how law enforcement agen-
cies will coordinate with their corresponding 
State substance abuse and mental health agen-
cies to identify protocols and resources that are 
available to victims and families, including in-
formation on treatment and recovery resources. 
‘‘(d) USE OF FUNDS.—An eligible entity shall use a 
grant received under this section to— 
‘‘(1) make naloxone available to be carried and 
administered by law enforcement officers; 
‘‘(2) train and provide resources for law en-
forcement officers on carrying and administering 
naloxone for the prevention of opioid and heroin 
overdose death; and 
‘‘(3) establish processes, protocols, and mecha-
nisms for referral to treatment. 
‘‘(e) GRANT AMOUNTS AND DURATION.— 
‘‘(1) MAXIMUM AMOUNT.—The Attorney Gen-
eral may not award a grant under this section in an 
amount that exceeds $500,000. 
‘‘(2) DURATION.—The Attorney General shall 
award grants under this section for a period not to 
exceed 2 years. 
‘‘(f) TECHNICAL ASSISTANCE GRANTS.—The Attor-
ney General shall make a grant for the purpose of pro-
VerDate Sep 11 2014 
02:36 Feb 25, 2015
Jkt 049200
PO 00000
Frm 00033
Fmt 6652
Sfmt 6201
E:\BILLS\H953.IH
H953
emcdonald on DSK67QTVN1PROD with BILLS
viding technical assistance and training on the use of 
naloxone to reverse overdose deaths and mechanisms for 
referral to treatment for an eligible entity receiving a 
grant under this section. 
‘‘(g) EVALUATION.—The Attorney General shall con-
duct an evaluation of grants made under this section to 
determine— 
‘‘(1) the number of officers equipped with 
naloxone for the prevention of fatal opioid and her-
oin overdose; 
‘‘(2) the number of opioid and heroin overdoses 
reversed by officers receiving training and supplies 
of naloxone through a grant received under this sec-
tion; 
‘‘(3) the number of calls for service related to 
opioid and heroin overdose; 
‘‘(4) the extent to which overdose victims and 
families receive information about treatment services 
and available data describing treatment admissions; 
and 
‘‘(5) the research, training, and naloxone supply 
needs of law enforcement and first responder agen-
cies, including those agencies that are not receiving 
grants under this section. 
VerDate Sep 11 2014 
02:36 Feb 25, 2015
Jkt 049200
PO 00000
Frm 00034
Fmt 6652
Sfmt 6201
E:\BILLS\H953.IH
H953
emcdonald on DSK67QTVN1PROD with BILLS
‘‘(h) AUTHORIZATION OF APPROPRIATIONS.—There 
are authorized to be appropriated to carry out this section 
$5,000,000 for each of fiscal years 2016 through 2020.’’. 
SEC. 203. PRESCRIPTION DRUG TAKE BACK EXPANSION. 
Part MM of the Omnibus Crime Control and Safe 
Streets Act of 1968, as amended by section 202, is amend-
ed by adding at the end the following: 
‘‘SEC. 3036. PRESCRIPTION DRUG TAKE BACK EXPANSION. 
‘‘(a) DEFINITION.—In this section, the term ‘eligible 
entity’ means— 
‘‘(1) a State, local, or tribal law enforcement 
agency; 
‘‘(2) a manufacturer, distributor, or reverse dis-
tributor of prescription medications; 
‘‘(3) a retail pharmacy; 
‘‘(4) a registered narcotic treatment program; 
‘‘(5) a hospital or clinic with an on-site phar-
macy; 
‘‘(6) an eligible long-term care facility; or 
‘‘(7) any other entity authorized by the Drug 
Enforcement Administration to dispose of prescrip-
tion medications. 
‘‘(b) PROGRAM AUTHORIZED.—The Attorney Gen-
eral, in coordination with the Administrator of the Drug 
Enforcement Administration, the Secretary of Health and 
VerDate Sep 11 2014 
02:36 Feb 25, 2015
Jkt 049200
PO 00000
Frm 00035
Fmt 6652
Sfmt 6201
E:\BILLS\H953.IH
H953
emcdonald on DSK67QTVN1PROD with BILLS
Human Services, and the Director of the Office of Na-
tional Drug Control Policy, may make grants to eligible 
entities to expand or make available disposal sites for un-
wanted prescription medications. 
‘‘(c) APPLICATION.— 
‘‘(1) IN GENERAL.—An eligible entity desiring a 
grant under this section shall submit an application 
to the Attorney General— 
‘‘(A) that meets the criteria under para-
graph (2); and 
‘‘(B) at such time, in such manner, and 
accompanied by such information as the Attor-
ney General may require. 
‘‘(2) CRITERIA.—An eligible entity, in submit-
ting an application under paragraph (1), shall— 
‘‘(A) describe the evidence-based method-
ology and outcome measurements that will be 
used to evaluate the program funded with a 
grant under this section, and specifically ex-
plain how such measurements will provide valid 
measures of the impact of the program; 
‘‘(B) describe how the program could be 
broadly replicated if demonstrated to be effec-
tive; and 
VerDate Sep 11 2014 
02:36 Feb 25, 2015
Jkt 049200
PO 00000
Frm 00036
Fmt 6652
Sfmt 6201
E:\BILLS\H953.IH
H953
emcdonald on DSK67QTVN1PROD with BILLS
‘‘(C) identify the governmental and com-
munity agencies that will coordinate the pro-
gram. 
‘‘(d) USE OF FUNDS.—An eligible entity shall use a 
grant received under this section for— 
‘‘(1) expenses of a prescription drug disposal 
site, including materials and resources; 
‘‘(2) implementing disposal procedures and 
processes; 
‘‘(3) implementing community education strate-
gies, including community education materials and 
resources; 
‘‘(4) replicating a prescription drug take back 
initiative throughout multiple jurisdictions; and 
‘‘(5) training of law enforcement officers and 
other community participants. 
‘‘(e) GRANT AMOUNTS AND DURATION.— 
‘‘(1) MAXIMUM AMOUNT.—The Attorney Gen-
eral may not award a grant under this section in an 
amount that exceeds $250,000. 
‘‘(2) DURATION.—The Attorney General shall 
award grants under this section for a period not to 
exceed 2 years. 
‘‘(f) TECHNICAL ASSISTANCE GRANT.—The Attorney 
General shall make a grant to a national nonprofit organi-
VerDate Sep 11 2014 
02:36 Feb 25, 2015
Jkt 049200
PO 00000
Frm 00037
Fmt 6652
Sfmt 6201
E:\BILLS\H953.IH
H953
emcdonald on DSK67QTVN1PROD with BILLS
zation to provide technical assistance and training for an 
eligible entity receiving a grant under this section. 
‘‘(g) EVALUATION.— 
‘‘(1) IN GENERAL.—The Attorney General shall 
make a grant for evaluation of the performance of 
each eligible entity receiving a grant under this sec-
tion. 
‘‘(2) REPORTS.—Each fiscal year, the recipient 
of a grant under this subsection shall submit to the 
Attorney General a report that evaluates— 
‘‘(A) the effectiveness of the prescription 
drug take back program of each eligible entity 
receiving a grant under this section; and 
‘‘(B) the effect of disposal efforts on drug 
circulation. 
‘‘(h) AUTHORIZATION OF APPROPRIATIONS.—There 
are authorized to be appropriated to carry out this section 
$2,500,000 for each of fiscal years 2016 through 2020.’’. 
TITLE III—TREATMENT AND 
RECOVERY 
SEC. 301. EVIDENCE-BASED OPIOID AND HEROIN TREAT-
MENT 
AND 
INTERVENTIONS 
DEMONSTRA-
TION. 
Subpart 1 of part B of title V of the Public Health 
Service Act (42 U.S.C. 290bb et seq.) is amended— 
VerDate Sep 11 2014 
02:36 Feb 25, 2015
Jkt 049200
PO 00000
Frm 00038
Fmt 6652
Sfmt 6201
E:\BILLS\H953.IH
H953
emcdonald on DSK67QTVN1PROD with BILLS
(1) by redesignating section 514 (42 U.S.C. 
290bb–9), as added by section 3632 of the Meth-
amphetamine Anti-Proliferation Act of 2000 (Public 
Law 106–310; 114 Stat. 1236), as section 514B; 
and 
(2) by adding at the end the following: 
‘‘SEC. 514C. EVIDENCE-BASED OPIOID AND HEROIN TREAT-
MENT 
AND 
INTERVENTIONS 
DEMONSTRA-
TION. 
‘‘(a) GRANTS.— 
‘‘(1) AUTHORITY TO MAKE GRANTS.—The Di-
rector of the Center for Substance Abuse Treatment 
(referred to in this section as the ‘Director’) may 
award grants to State substance abuse agencies, 
units of local government, nonprofit organizations, 
and Indian tribes or tribal organizations (as defined 
in section 4 of the Indian Health Care Improvement 
Act (25 U.S.C. 1603)) that have a high rate, or 
have had a rapid increase, in the use of heroin or 
other opioids, in order to permit such entities to ex-
pand activities, including an expansion in the avail-
ability of medication assisted treatment, with respect 
to the treatment of addiction in the specific geo-
graphical areas of such entities where there is a rate 
VerDate Sep 11 2014 
02:36 Feb 25, 2015
Jkt 049200
PO 00000
Frm 00039
Fmt 6652
Sfmt 6201
E:\BILLS\H953.IH
H953
emcdonald on DSK67QTVN1PROD with BILLS
or rapid increase in the use of heroin or other 
opioids. 
‘‘(2) 
RECIPIENTS.—The 
entities 
receiving 
grants under paragraph (1) shall be selected by the 
Director. 
‘‘(3) NATURE OF ACTIVITIES.—The grant funds 
awarded under paragraph (1) shall be used for ac-
tivities that are based on reliable scientific evidence 
of efficacy in the treatment of problems related to 
heroin or other opioids. 
‘‘(b) GEOGRAPHIC
DISTRIBUTION.—The Director 
shall ensure that grants awarded under subsection (a) are 
distributed equitably among the various regions of the Na-
tion and among rural, urban, and suburban areas that are 
affected by the use of heroin or other opioids. 
‘‘(c) ADDITIONAL ACTIVITIES.—The Director shall— 
‘‘(1) evaluate the activities supported by grants 
awarded under subsection (a); 
‘‘(2) disseminate widely such significant infor-
mation derived from the evaluation as the Director 
considers appropriate; 
‘‘(3) provide States, Indian tribes and tribal or-
ganizations, and providers with technical assistance 
in connection with the provision of treatment of 
problems related to heroin and other opioids; and 
VerDate Sep 11 2014 
02:36 Feb 25, 2015
Jkt 049200
PO 00000
Frm 00040
Fmt 6652
Sfmt 6201
E:\BILLS\H953.IH
H953
emcdonald on DSK67QTVN1PROD with BILLS
‘‘(4) fund only those applications that specifi-
cally support recovery services as a critical compo-
nent of the grant program. 
‘‘(d) DEFINITION.—The term ‘medication assisted 
treatment’ means the use, for problems relating to heroin 
and other opioids, of medications approved by the Food 
and Drug Administration in combination with counseling 
and behavioral therapies. 
‘‘(e) AUTHORIZATION OF APPROPRIATIONS.— 
‘‘(1) IN GENERAL.—There are authorized to be 
appropriated to carry out this section $12,000,000 
for fiscal year 2016 and such sums as may be nec-
essary for each of fiscal years 2016 through 2020. 
‘‘(2) USE OF CERTAIN FUNDS.—Of the funds 
appropriated to carry out this section in any fiscal 
year, the lesser of 5 percent of such funds or 
$1,000,000 shall be available to the Director for 
purposes of carrying out subsection (c).’’. 
SEC. 
302. 
CRIMINAL 
JUSTICE 
MEDICATION 
ASSISTED 
TREATMENT 
AND 
INTERVENTIONS 
DEM-
ONSTRATION. 
Part MM of the Omnibus Crime Control and Safe 
Streets Act of 1968, as amended by section 203, is amend-
ed by adding at the end the following: 
VerDate Sep 11 2014 
02:36 Feb 25, 2015
Jkt 049200
PO 00000
Frm 00041
Fmt 6652
Sfmt 6201
E:\BILLS\H953.IH
H953
emcdonald on DSK67QTVN1PROD with BILLS
‘‘SEC. 3037. CRIMINAL JUSTICE MEDICATION ASSISTED 
TREATMENT 
AND 
INTERVENTIONS 
DEM-
ONSTRATION. 
‘‘(a) DEFINITIONS.—In this section— 
‘‘(1) the term ‘criminal justice agency’ means a 
State, local, or tribal— 
‘‘(A) court; 
‘‘(B) prison; 
‘‘(C) jail; or 
‘‘(D) other agency that performs the ad-
ministration of criminal justice, including pros-
ecution, pretrial services, and community super-
vision; and 
‘‘(2) the term ‘eligible entity’ means a State, 
unit of local government, or Indian tribe. 
‘‘(b) PROGRAM AUTHORIZED.—The Attorney Gen-
eral, in coordination with the Secretary of Health and 
Human Services and the Director of the Office of National 
Drug Control Policy, may make grants to eligible entities 
to implement medication assisted treatment programs 
through criminal justice agencies. 
‘‘(c) APPLICATION.— 
‘‘(1) IN GENERAL.—An eligible entity desiring a 
grant under this section shall submit an application 
to the Attorney General— 
VerDate Sep 11 2014 
02:36 Feb 25, 2015
Jkt 049200
PO 00000
Frm 00042
Fmt 6652
Sfmt 6201
E:\BILLS\H953.IH
H953
emcdonald on DSK67QTVN1PROD with BILLS
‘‘(A) that meets the criteria under para-
graph (2); and 
‘‘(B) at such time, in such manner, and 
accompanied by such information as the Attor-
ney General may require. 
‘‘(2) CRITERIA.—An eligible entity, in submit-
ting an application under paragraph (1), shall— 
‘‘(A) certify that each medication assisted 
treatment program funded with a grant under 
this section has been developed in consultation 
with the Single State Authority for Substance 
Abuse; and 
‘‘(B) describe how data will be collected 
and analyzed to determine the effectiveness of 
the program described in subparagraph (A). 
‘‘(d) USE OF FUNDS.—An eligible entity shall use a 
grant received under this section for expenses of— 
‘‘(1) a medication assisted treatment program, 
including the expenses of prescribing medications 
recognized by the Food and Drug Administration for 
opioid treatment in conjunction with psychological 
and behavioral therapy; 
‘‘(2) training criminal justice agency personnel 
and treatment providers on medication assisted 
treatment; 
VerDate Sep 11 2014 
02:36 Feb 25, 2015
Jkt 049200
PO 00000
Frm 00043
Fmt 6652
Sfmt 6201
E:\BILLS\H953.IH
H953
emcdonald on DSK67QTVN1PROD with BILLS
‘‘(3) cross-training personnel providing behav-
ioral health and health services, administration of 
medicines, and other administrative expenses, includ-
ing required reports; and 
‘‘(4) the provision of recovery coaches who are 
responsible for providing mentorship and transition 
plans to individuals reentering society following in-
carceration or alternatives to incarceration. 
‘‘(e) GRANT AMOUNTS AND DURATION.— 
‘‘(1) MAXIMUM AMOUNT.—The Attorney Gen-
eral may not award a grant under this section in an 
amount that exceeds $750,000. 
‘‘(2) DURATION.—The Attorney General shall 
award grants under this section for a period not to 
exceed 2 years. 
‘‘(f) PRIORITY CONSIDERATION WITH RESPECT TO 
STATES.—In awarding grants to States under this sec-
tion, the Attorney General shall give priority to a State 
that provides civil liability protection for first responders, 
health professionals, and family members administering 
naloxone to counteract opioid overdoses by— 
‘‘(1) enacting legislation that provides such civil 
liability protection; or 
‘‘(2) providing a certification by the attorney 
general of the State that the attorney general has— 
VerDate Sep 11 2014 
02:36 Feb 25, 2015
Jkt 049200
PO 00000
Frm 00044
Fmt 6652
Sfmt 6201
E:\BILLS\H953.IH
H953
emcdonald on DSK67QTVN1PROD with BILLS
‘‘(A) reviewed any applicable civil liability 
protection law to determine the applicability of 
the law with respect to first responders, health 
care professionals, family members, and other 
individuals who may administer naloxone to in-
dividuals reasonably believed to be suffering 
from opioid overdose; and 
‘‘(B) concluded that the law described in 
subparagraph (A) provides adequate civil liabil-
ity protection applicable to such persons. 
‘‘(g) TECHNICAL ASSISTANCE.—The Attorney Gen-
eral, in coordination with the Director of the National In-
stitute on Drug Abuse and the Secretary of Health and 
Human Services, shall provide technical assistance and 
training for an eligible entity receiving a grant under this 
section. 
‘‘(h) REPORTS.— 
‘‘(1) IN GENERAL.—An eligible entity receiving 
a grant under this subsection shall submit a report 
to the Attorney General on the outcomes of each 
grant received under this section for individuals re-
ceiving medication assisted treatment, based on— 
‘‘(A) the recidivism of the individuals; 
‘‘(B) the treatment outcomes of the indi-
viduals, including maintaining abstinence from 
VerDate Sep 11 2014 
02:36 Feb 25, 2015
Jkt 049200
PO 00000
Frm 00045
Fmt 6652
Sfmt 6201
E:\BILLS\H953.IH
H953
emcdonald on DSK67QTVN1PROD with BILLS
illegal, unauthorized, and unprescribed or 
undispensed opioids and heroin; 
‘‘(C) a comparison of the cost of providing 
medication assisted treatment to the cost of in-
carceration or other participation in the crimi-
nal justice system; 
‘‘(D) the housing status of the individuals; 
and 
‘‘(E) the employment status of the individ-
uals. 
‘‘(2) CONTENTS AND TIMING.—Each report de-
scribed in paragraph (1) shall be submitted annually 
in such form, containing such information, and on 
such dates as the Attorney General shall specify. 
‘‘(i) AUTHORIZATION OF APPROPRIATIONS.—There 
are authorized to be appropriated to carry out this section 
$5,000,000 for each of fiscal years 2016 through 2020.’’. 
SEC. 303. NATIONAL YOUTH RECOVERY INITIATIVE. 
(a) DEFINITIONS.—In this section: 
(1) ELIGIBLE ENTITY.—The term ‘‘eligible enti-
ty’’ means— 
(A) a high school that has been accredited 
as a recovery high school by the Association of 
Recovery Schools; 
VerDate Sep 11 2014 
02:36 Feb 25, 2015
Jkt 049200
PO 00000
Frm 00046
Fmt 6652
Sfmt 6201
E:\BILLS\H953.IH
H953
emcdonald on DSK67QTVN1PROD with BILLS
(B) an accredited high school that is seek-
ing to establish or expand recovery support 
services; 
(C) an institution of higher education; 
(D) a recovery program at a nonprofit col-
legiate institution; or 
(E) a nonprofit organization. 
(2) INSTITUTION OF HIGHER EDUCATION.—The 
term ‘‘institution of higher education’’ has the 
meaning given the term in section 101 of the Higher 
Education Act of 1965 (20 U.S.C. 1001). 
(3) RECOVERY PROGRAM.—The term ‘‘recovery 
program’’— 
(A) means a program to help individuals 
who are recovering from substance use dis-
orders to initiate, stabilize, and maintain 
healthy and productive lives in the community; 
and 
(B) includes peer-to-peer support and com-
munal activities to build recovery skills and 
supportive social networks. 
(b) GRANTS AUTHORIZED.—The ONDCP Recovery 
Branch, in consultation with the Secretary of Education, 
may award grants to eligible entities to enable the entities 
to— 
VerDate Sep 11 2014 
02:36 Feb 25, 2015
Jkt 049200
PO 00000
Frm 00047
Fmt 6652
Sfmt 6201
E:\BILLS\H953.IH
H953
emcdonald on DSK67QTVN1PROD with BILLS
(II) not fewer than 1 one of 
whom has benefited from medication 
assisted treatment; and 
(iii) to the extent practicable, mem-
bers who formerly served as elected offi-
cials at the State and Federal levels. 
(C) TIMING.—The Secretary shall appoint 
the members of the Task Force not later than 
60 days after the date on which the Task Force 
is established under paragraph (1). 
(3) CHAIRPERSON.—The Task Force shall se-
lect a chairperson or co-chairpersons from among 
the members of the Task Force. 
(c) DUTIES OF THE TASK FORCE.— 
(1) IN GENERAL.—The Task Force shall— 
(A) identify collateral consequences for in-
dividuals with Federal or State drug convictions 
who are in recovery for substance use disorder; 
and 
(B) determine whether the collateral con-
sequences identified under subparagraph (A) 
unnecessarily delay individuals in recovery from 
resuming their personal and professional activi-
ties. 
VerDate Sep 11 2014 
02:36 Feb 25, 2015
Jkt 049200
PO 00000
Frm 00060
Fmt 6652
Sfmt 6201
E:\BILLS\H953.IH
H953
emcdonald on DSK67QTVN1PROD with BILLS